Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 298 entries
View as:

Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00136175 Org: User:
Start: 11/30/99 End: 10/31/07 Due: 10/31/08

A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02409121 Org: User:
Start: 09/30/15 End: 12/09/18 Due: 12/09/19

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06914479 Org: User:
Start: 06/01/25 End: 06/01/30 Due: 06/01/31

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

Phase: N/A Priority: Normal
NCT ID: NCT04748042 Org: User:
Start: 05/28/21 End: 12/31/25 Due: 12/31/26

RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.

Phase: N/A Priority: Normal
NCT ID: NCT01188889 Org: User:
Start: 09/30/13 End: 12/31/17 Due: 12/31/18

Early Assessment of Treatment Response Using Functional Diffusion Mapping

Phase: N/A Priority: Normal
NCT ID: NCT02064283 Org: User:
Start: 05/31/07 End: 10/31/12 Due: 10/31/13

Phase II Study of Resistant Potato Starch Plus Deferasirox to Improve Outcomes in Patients Undergoing Allogeneic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06784336 Org: User:
Start: 08/31/25 End: 08/31/29 Due: 08/31/30

Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma

Phase: N/A Priority: Normal
NCT ID: NCT04051047 Org: User:
Start: 11/30/19 End: 12/31/21 Due: 12/31/22

A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response

Phase: N/A Priority: Normal
NCT ID: NCT01209962 Org: User:
Start: 05/31/08 End: 05/26/15 Due: 05/26/16

Radiation Therapy With Capecitabine in Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00176787 Org: User:
Start: 10/31/00 End: 06/30/07 Due: 06/30/08

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01912612 Org: User:
Start: 10/30/13 End: 06/28/19 Due: 06/28/20

Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02485470 Org: User:
Start: 02/29/16 End: 10/31/18 Due: 10/31/19

Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06228768 Org: User:
Start: 03/06/24 End: 05/31/26 Due: 05/31/27

Partial Breast Irradiation Using Accelerated Intensity Modulated Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00581529 Org: User:
Start: 11/30/04 End: 08/31/14 Due: 08/31/15

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00639717 Org: User:
Start: 03/31/09 End: 04/30/16 Due: 04/30/17

A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02463994 Org: User:
Start: 10/31/15 End: 11/07/18 Due: 11/07/19

Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00151060 Org: User:
Start: 12/31/98 End: 06/30/06 Due: 06/30/07

Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE)

Phase: N/A Priority: Normal
NCT ID: NCT02997956 Org: User:
Start: 07/31/17 End: 07/31/22 Due: 07/31/23

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04477200 Org: User:
Start: 08/05/20 End: 11/05/27 Due: 11/05/28

Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03416153 Org: User:
Start: 05/21/18 End: 05/05/25 Due: 05/05/26

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06442891 Org: User:
Start: 10/01/24 End: 12/01/26 Due: 12/01/27

Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site

Phase: N/A Priority: Normal
NCT ID: NCT00148135 Org: User:
Start: 05/31/01 End: 10/31/07 Due: 10/31/08

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Phase: N/A Priority: Normal
NCT ID: NCT00843375 Org: User:
Start: 08/07/19 End: 03/31/28 Due: 03/31/29

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

Phase: N/A Priority: Normal
NCT ID: NCT06617455 Org: User:
Start: 10/31/24 End: 10/01/26 Due: 10/01/27

Expansion Trial for Axitinib In Head And Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02762513 Org: User:
Start: 08/30/16 End: 04/09/20 Due: 04/09/21